Emerging trends in high-throughput screening.
暂无分享,去创建一个
[1] John Davies,et al. Design of small molecule libraries for NMR screening and other applications in drug discovery. , 2002, Current topics in medicinal chemistry.
[2] T. Chiba,et al. Exploring the protein interactome using comprehensive two-hybrid projects. , 2001, Trends in biotechnology.
[3] Gary D Bader,et al. Systematic Genetic Analysis with Ordered Arrays of Yeast Deletion Mutants , 2001, Science.
[4] Martin Vogtherr,et al. NMR-based screening methods for lead discovery. , 2003, EXS.
[5] H. Blau,et al. Monitoring protein-protein interactions in live mammalian cells by beta-galactosidase complementation. , 2000, Methods in enzymology.
[6] Marina Veronesi,et al. Fluorine-NMR competition binding experiments for high-throughput screening of large compound mixtures. , 2002, Combinatorial chemistry & high throughput screening.
[7] S. Rees,et al. Application of β-Galactosidase Enzyme Complementation Technology as a High Throughput Screening Format for Antagonists of the Epidermal Growth Factor Receptor , 2001 .
[8] Ajay,et al. Designing libraries with CNS activity. , 1999, Journal of medicinal chemistry.
[9] H. Blau,et al. Protein–protein interactions monitored in mammalian cells via complementation of β-lactamase enzyme fragments , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[10] K. Comess,et al. Complex Gel Permeation Assays for Screening Combinatorial Libraries , 2001, Journal of biomolecular screening.
[11] Rudi Verbeeck,et al. Outlier Mining in High Throughput Screening Experiments , 2002, Journal of biomolecular screening.
[12] H. Blau,et al. Interaction blues: protein interactions monitored in live mammalian cells by beta-galactosidase complementation. , 2000, Trends in cell biology.
[13] Mitchell A. Miller. Chemical database techniques in drug discovery , 2002, Nature Reviews Drug Discovery.
[14] T. Kenakin,et al. Quantitative Molecular Pharmacology and Informatics in Drug Discovery , 2000 .
[15] J. Kofron,et al. Application of Micro Arrayed Compound Screening (pcARCS) to Identify Inhibitors of Caspase-3 , 2002, Journal of biomolecular screening.
[16] J Mestres. Virtual screening: a real screening complement to high-throughput screening. , 2002, Biochemical Society transactions.
[17] Derek J Trezise,et al. IonWorks™ HT: A New High-Throughput Electrophysiology Measurement Platform , 2003, Journal of biomolecular screening.
[18] T. Garyantes,et al. Development and Evaluation of High Throughput Functional Assay Methods for hERG Potassium Channel , 2001, Journal of biomolecular screening.
[19] J. Drews. Drug discovery: a historical perspective. , 2000, Science.
[20] R. Eglen,et al. Beta galactosidase enzyme fragment complementation as a novel technology for high throughput screening. , 2003, Combinatorial chemistry & high throughput screening.
[21] M. Palmer,et al. Cell-Based High-Throughput Screening Assay System for Monitoring G Protein-Coupled Receptor Activation Using β-Galactosidase Enzyme Complementation Technology , 2002, Journal of biomolecular screening.
[22] Qifeng Xue,et al. Multiplexed enzyme assays in capillary electrophoretic single‐use microfluidic devices , 2001, Electrophoresis.
[23] J. Kofron,et al. Microarray Compound Screening (μARCS) to Identify Inhibitors of HIV Integrase , 2002 .
[24] P. Hajduk,et al. Integration of NMR and high-throughput screening. , 2002, Combinatorial chemistry & high throughput screening.
[25] Ye Fang,et al. Membrane protein microarrays. , 2002, Journal of the American Chemical Society.
[26] J. Mason,et al. New 4-point pharmacophore method for molecular similarity and diversity applications: overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures. , 1999, Journal of medicinal chemistry.
[27] J. Greef,et al. Mass spectrometry–based bioassay for the screening of soluble orphan receptors , 2001 .
[28] Ruedi Stoop,et al. An Ontology for Pharmaceutical Ligands and Its Application for in Silico Screening and Library Design , 2002, J. Chem. Inf. Comput. Sci..
[29] Jeremy L Jenkins,et al. Virtual screening to enrich hit lists from high‐throughput screening: A case study on small‐molecule inhibitors of angiogenin , 2002, Proteins.
[30] Didier Rognan,et al. Protein‐based virtual screening of chemical databases. II. Are homology models of g‐protein coupled receptors suitable targets? , 2002, Proteins.
[31] Charles J. Manly,et al. The impact of informatics and computational chemistry on synthesis and screening. , 2001, Drug discovery today.
[32] Ye Fang,et al. G‐Protein‐Coupled Receptor Microarrays , 2002, Chembiochem : a European journal of chemical biology.
[33] J. van der Greef,et al. Potential of on-line micro-LC immunochemical detection in the bioanalysis of cytokines. , 2001, Journal of pharmaceutical and biomedical analysis.
[34] S. Frantz,et al. New drug approvals for 2002 , 2003, Nature Reviews Drug Discovery.
[35] Claudio Dalvit,et al. Fluorine-NMR experiments for high-throughput screening: theoretical aspects, practical considerations, and range of applicability. , 2003, Journal of the American Chemical Society.
[36] Michael Fejtl,et al. The roboocyte: automated cDNA/mRNA injection and subsequent TEVC recording on Xenopus oocytes in 96-well microtiter plates. , 2003, Receptors & channels.
[37] R. Moaddel,et al. Immobilized nicotinic receptor stationary phases: going with the flow in high-throughput screening and pharmacological studies. , 2003, Journal of pharmaceutical and biomedical analysis.
[38] Alexander Tropsha,et al. Rational principles of compound selection for combinatorial library design. , 2002, Combinatorial chemistry & high throughput screening.
[39] Victor S. Lobanov,et al. High-Density Miniaturized Thermal Shift Assays as a General Strategy for Drug Discovery , 2001 .
[40] Jürgen Bajorath,et al. Integration of virtual and high-throughput screening , 2002, Nature Reviews Drug Discovery.
[41] R. Eglen,et al. A High-Throughput, Nonisotopic, Competitive Binding Assay for Kinases Using Nonselective Inhibitor Probes (ED-NSIP™) , 2002, Journal of biomolecular screening.
[42] Kurt Wüthrich,et al. Nmr in drug discovery , 2002, Nature Reviews Drug Discovery.
[43] R. Ozawa,et al. A comprehensive two-hybrid analysis to explore the yeast protein interactome , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[44] K L Spear,et al. Retrospective analysis of an experimental high-throughput screening data set by recursive partitioning. , 2001, Journal of combinatorial chemistry.
[45] H. Irth,et al. High Resolution Screening of Plant Natural Product Extracts for Estrogen Receptor a and f3 Binding Activity Using an Online HPLC-MS Biochemical Detection System , 2001, Journal of biomolecular screening.
[46] S. Pochapsky,et al. Nuclear magnetic resonance as a tool in drug discovery, metabolism and disposition. , 2001, Current topics in medicinal chemistry.
[47] Stanley Fields,et al. A yeast sensor of ligand binding , 2001, Nature Biotechnology.
[48] T. Garyantes,et al. Identification of Gap Junction Blockers Using Automated Fluorescence Microscopy Imaging , 2003, Journal of biomolecular screening.